Literature DB >> 17560820

Neurological and brain MRS findings in patients with Gaucher disease type 1.

Saadet Mercimek-Mahmutoglu1, Stephan Gruber, Arndt Rolfs, Andreas Stadlbauer, Christian Woeber, Peter Kurnik, Till Voigtlaender, Ewald Moser, Sylvia Stoeckler-Ipsiroglu.   

Abstract

Gaucher disease type 1 (GD1) is an autosomal recessive lysosomal storage disorder, characterised by accumulation of glycosphingolipids in visceral organs. Although considered non-neuronopathic neurological involvement has been reported in single cases. The aim of our study was to investigate central and peripheral nervous system involvement in patients with GD1. We investigated nine unrelated patients with GD1 by three-dimensional cerebral 1H-magnetic resonance spectroscopic imaging and clinical and neurophysiological tests. We found an increased choline level on MRS in four patients. One of these patients had mixed axonal neuropathy and subclinical involvement of the central somatosensory tract as well as monoclonal gammopathy. One patient with normal cerebral choline levels had evidence of bilateral carpal tunnel syndrome upon neurophysiological exam. The N370S mutation was found in 11 out of 18 alleles. Three patients were compound heterozygous for the L444P mutation. There was no correlation between increased cerebral choline levels and type of mutations. MRS findings suggest that in patients with classical non-neuronopathic GD1, the brain is involved at a subclinical level in some patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560820     DOI: 10.1016/j.ymgme.2007.03.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy.

Authors:  Reena V Kartha; James Joers; Marcia R Terluk; Abigail Travis; Kyle Rudser; Paul J Tuite; Neal J Weinreb; Jeanine R Jarnes; James C Cloyd; Gülin Öz
Journal:  J Inherit Metab Dis       Date:  2019-12-17       Impact factor: 4.982

2.  Thalamic and dentate nucleus abnormalities in the brain of children with Gaucher disease.

Authors:  Giulia Perucca; Bruno P Soares; Serena Staglianò; James Davison; Anupam Chakrapani; Felice D'Arco
Journal:  Neuroradiology       Date:  2018-10-17       Impact factor: 2.804

3.  Apparent diffusion coefficient vale of the brain in patients with Gaucher's disease type II and type III.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nahed Abd El-Gaber; Ahmed Abdalla; Abeer Fathy; Ahmed Azab; Ashraf Abdel Rahman
Journal:  Neuroradiology       Date:  2009-07-15       Impact factor: 2.804

Review 4.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

5.  Proton MR Spectroscopy of the brain in children with neuronopathic Gaucher's disease.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Nahed Abdel Gaber; Abeer Fathy; Ahmed Megahed; Tarek Barakat; Mona Abdel Latif Alsayed
Journal:  Eur Radiol       Date:  2013-06-20       Impact factor: 5.315

Review 6.  Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement.

Authors:  Andrew J Degnan; Victor M Ho-Fung; Rebecca C Ahrens-Nicklas; Christian A Barrera; Suraj D Serai; Dah-Jyuu Wang; Can Ficicioglu
Journal:  Insights Imaging       Date:  2019-07-10

7.  Polyneuropathy in Gaucher disease type 1 and 3 - a descriptive case series.

Authors:  Mattias Andréasson; Göran Solders; Cecilia K Björkvall; Maciej Machaczka; Per Svenningsson
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.